Associate Director, Advanced Analytics Global Rare

. As Associate Director, Advanced Analytics Global Rare, you will be the key analytics strategic partner for Rare business leaders..., and Rare business objectives will ensure robust integrated delivery for headquarters, customer, and patient-facing teams...

Lugar: USA | 27/03/2026 18:03:20 PM | Salario: S/. No Especificado | Empresa: Alnylam Pharmaceuticals

Rare Disease Sales Consultant

. If you thrive in a highly specialized, customer-focused environment and want to make an impact in rare disease care..., this is your opportunity! Your Role: As a Rare Disease Sales Consultant, you will execute LEO Pharma's dermatology sales and marketing...

Lugar: Saint Louis, MO | 26/03/2026 22:03:51 PM | Salario: S/. $145000 - 200000 per year | Empresa: Leo Pharma

Observational Research Senior Manager (Rare Disease)

of. Join us. Observational Research Senior Manager - Rare Disease Live What you will do Let’s do this. Let’s change the world. In this vital... role you will responsible for research activities on the Rare Disease therapeutic area team. The CfOR Senior Manager...

Lugar: USA | 26/03/2026 19:03:24 PM | Salario: S/. $165267 - 186141 per year | Empresa: Amgen

Head of Finance - Rare Disease and Medical

Job title: Head of Finance - Rare Disease and Medical Location: Cambridge, MA About the job Ready to push the... of what's possible? Join Sanofi as a Finance Business Partner and become a catalyst for innovation in our Rare Disease portfolio and country Medical...

Lugar: Cambridge, MA | 26/03/2026 18:03:20 PM | Salario: S/. No Especificado | Empresa: Sanofi

Ultra-Rare Disease Territory Account Specialist – Hartford, CT

is accessible to you. Company will not sponsor visas for this position. The Ultra‑Rare Disease Territory Account Specialist... patient outcomes. Operating with autonomy in a highly dynamic environment, the Ultra‑Rare Disease Territory Account Specialist...

Lugar: Hartford, CT | 26/03/2026 03:03:25 AM | Salario: S/. No Especificado | Empresa: Novartis